A look back at the week's news.
COVID-19 vaccination during pregnancy may reduce infants’ risk of infection during the early months of life, according to a recent study.
A prospective study published in the International Scientific Research Journal has found that colposcopy was able to detect exoservicitis in about one-third of women with uterine fibroids.
Uterine cancer is currently the only cancer type not covered by the World Trade Center (WTC) Health Program.
A research letter published in JAMA Network Open has found no difference in clinical outcomes for in vitro fertilization (IVF) via intracytoplasmic sperm injection (ICSI) between COVID-19 vaccinated and unvaccinated women of reproductive age.
Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.
Currently approved for the treatment of vulvovaginal candidiasis (VVC), and if the sNDA is approved, ibrexafungerp (Brexafemme; Scynexis) would be the first and only oral non-azole medication for the prevention of recurrent VVC.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More